Study Selection
For the efficacy review, the search outputs were
scrutinized to identify all SJW or SAM-e studies
that met the following criteria:
!"Randomized, double-blind, placebo-controlled,
parallel group design
!"Minimum of 20 subjects per SJW or SAM-e
treatment arms
!"Limited to patients with MDD defined by DSM
and/or ICD as their predominant psychiatric
illness
!"Use of traditional clinician-rated assessments for
rating depression severity (e.g., HAM-D,
MADRS)
!"Used standard approaches for assessing treatment
effect (i.e., change from baseline, or
standard response or remission criteria)
!"Product tested alone (not a combination
treatment) and compared to placebo
!"Presented data from an intention-to-treat (ITT)
dataset